Trials / Sponsors / Omar Nadeem, MD
Omar Nadeem, MD
Academic / Other · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM Myeloma, Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 / Phase 2 | 2024-11-01 |
| Active Not Recruiting | DARA RVD For High Risk SMM High-risk Smoldering Multiple Myeloma, Multiple Myeloma | Phase 2 | 2021-03-08 |
| Active Not Recruiting | Ixazomib + Pomalidomide + Dexamethasone In MM Multiple Myeloma, Multiple Myeloma in Relapse | Phase 1 / Phase 2 | 2019-09-18 |